BioCentury
ARTICLE | Company News

Genzyme, Arecor in formulation deal

April 14, 2010 12:58 AM UTC

Arecor Ltd. (Cambridge, U.K.) said it will collaborate with Genzyme Corp. (NASDAQ:GENZ) to develop stable formulations of labile biologics from Genzyme's pipeline using Arecor's Arestat technology. Ar...